Events

Next National Advisory Council on Drug Abuse Meeting: September 11 The National Advisory Council on Drug Abuse (NACDA) serves a crucial role in advising NIDA, and, by extension, the Director, NIH and the Secretary, DHHS, as NIDA identifies, reviews, and supports the highest caliber of scientific research. The next NACDA meeting will take place Wednesday, […]

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 September 12, 2024 ­– Webinar 8:45 am-5:45pm Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 This demonstration of how to submit establishment registration and drug listing data using CDER Direct will feature case studies for an interactive learning experience. LinkedIn: SBIA|Webinar: […]

Sex Differences in Addiction Workshop  Organized in conjunction with ACU’s Healthy Brain and Mind Research Centre, experts from the National Institute on Drug Abuse, and the ENIGMA consortium When: Friday 27 September 2024 (1pm – 4.30pm PDT, see other timezones) Where: Online via Zoom Registration: https://forms.gle/LxCPPCPUVtpHL24n9 Find more info at: https://enigma.ini.usc.edu/events/upcoming-events/ Erynn, on behalf of the Sex Differences in Addiction Organising […]

NABR Webinar: “Current and Future Challenges Facing Biomedical Research” Please join us on Tuesday, Oct. 8, at 12:30 p.m. EST for the 61st NABR webinar when Matt Bailey, President of NABR and FBR; Brandon Morton, NABR’s Director of Government Affairs; and Taylor Bennett, NABR’s Senior Scientific Advisor, sit down to discuss the “Current and Future […]

Professional NIH Grant Development Live Online Workshop October 15-16, 2024 10:30 a.m. to 6:00 p.m. Eastern Time Sponsored by the Grant Training Center The Professional NIH Grant Development live online workshop, which is normally held at the University of Pennsylvania, has moved online. It will include the same content and length of instruction. You will […]

FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities REGISTRATION IS OPEN On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus […]

Advancing Smoking Cessation: FDA and NIH Priorities Attend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Goals and Objectives:  This public meeting will address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. […]

Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of […]

January 30 | Demystifying Medications for Substance Use Disorder @ 2 p.m. ET Save the date for this upcoming event! https://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month

"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1) "Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management, emerging adults often encounter significant challenges, including unmet needs in employment, housing, and social support. […]

NABR Webinar: “The FY 2024 USDA Oversight Process” Please join us on Jan. 14, 2025, at 12:30 p.m. EST for the first of NABR’s 2025 Webinar series, “The FY 2024 USDA Oversight Process.” Each year NABR obtains information from the USDA’s Animal Care Inspection System database using the Public Search Tool to review the inspection results […]